InvestorsObserver
×
News Home

Organovo Holdings Inc (ONVO) Stock: What Does the Chart Say Monday?

Monday, November 20, 2023 01:18 PM | InvestorsObserver Analysts

Mentioned in this article

Organovo Holdings Inc (ONVO) Stock: What Does the Chart Say Monday?

Organovo Holdings Inc (ONVO) stock is lower by 11.19% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bearish
Organovo Holdings Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on ONVO!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With ONVO Stock Today?

Organovo Holdings Inc (ONVO) stock has fallen -8.58% while the S&P 500 has gained 0.63% as of 1:05 PM on Monday, Nov 20. ONVO has fallen -$0.12 from the previous closing price of $1.39 on volume of 114,551 shares. Over the past year the S&P 500 has risen 15.00% while ONVO has fallen -18.59%. ONVO lost -$2.15 per share in the over the last 12 months.

More About Organovo Holdings Inc

Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels. Click Here to get the full Stock Report for Organovo Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App